Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.
作者信息
Yamagishi Sho-ichi, Ishibashi Yuji, Ojima Ayako, Sugiura Tatsushi, Matsui Takanori
机构信息
Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
出版信息
Int J Cardiol. 2014 Sep 20;176(2):550-2. doi: 10.1016/j.ijcard.2014.07.023. Epub 2014 Jul 12.
PMID:25065332
Abstract
摘要
Zotero 插件